Literature DB >> 361075

Metabolism of prostacyclin in rat.

F F Sun, B M Taylor.   

Abstract

Following a single intravenous administration of [11-3H]prostacyclin in rat, 77% of the administered dose was excreted within 3 days with 33% in urine and 44% in feces. Urinary metabolites were accumulated by chronic intravenous infusions of [11-3H]prostacyclin for 14 days. The drug was extensively metabolized and the structures of seven metabolites were elucidated by combined gas chromatography and mass spectrometry. The urinary products include the dinor and 19-hydroxy dinor derivatives of 6-keto-PGF1alpha and 13,14-dihydro-6,15-diketo-PGF1alpha, omega-hydroxy and omega-carboxyl dinor derivates of dihydro-6,15-diketo-PGF1alpha, and a dihydrodiketotetranordicarboxylic acid. The metabolic pathways of PGI2 in rat are similar to that of PGF2alpha.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361075     DOI: 10.1021/bi00612a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells.

Authors:  P N Belloni; R J Tressler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

2.  The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.

Authors:  K Schrör; H Darius; R Matzky; R Ohlendorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

Review 3.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

Review 4.  Administration of Inhaled Pulmonary Vasodilators to the Mechanically Ventilated Neonatal Patient.

Authors:  Michael D Davis; Steven M Donn; Robert M Ward
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

5.  Urinary excretion of 6-keto prostaglandin F1 alpha in pre-eclampsia.

Authors:  M Yamaguchi; N Mori
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

6.  The effect of linoleic, arachidonic and eicosapentaenoic acid supplementation on prostacyclin production in rats.

Authors:  N J Mann; G E Warrick; K O'Dea; H R Knapp; A J Sinclair
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

7.  Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance.

Authors:  J G Gerber; N A Payne; R C Murphy; A S Nies
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Mass spectrometric identification of urinary and plasma metabolites of 2-(6'-carboxyhexyl)-3-n-hexylcyclohexylamine, a new antiaggregating agent.

Authors:  E Benfenati; R Fanelli; E Bosone; R Caponi; P Farina
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Apr-Jun       Impact factor: 2.441

9.  Use of prostaglandin I2 analog in treatment of massive hepatic necrosis associated with endothelial cell injury and diffuse sinusoidal fibrin deposition.

Authors:  K Fujiwara; S Mochida; A Ohno; M Arai; A Matsui; N Masaki; K Hirata; T Tomiya; M Yamaoka; S Nagoshi
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

10.  Prostaglandins mediate the vasodilatory effect of mannitol in the hypoperfused rat kidney.

Authors:  P A Johnston; D B Bernard; N S Perrin; N G Levinsky
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.